Dr.Reddy's Labs gets CDSCO Panel Nod To Manufacture, Market anti-cancer drug Lenalidomide 20mg additional strength Dr. Divya Colin19 April 2024 6:00 PM ISTNew Delhi: The drug major Dr Reddy's Labs has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Dr. Reddy's gets CDSCO panel Nod To market Omeprazole Delayed-release orally disintegrating tablets Dr. Divya Colin4 March 2024 6:00 PM ISTNew Delhi: In a significant development, the drug major Dr. Reddy's Laboratories has got a go-ahead from the Subject Expert Committee (SEC) functional...
Add geographically distributed Govt sites: CDSCO Panel tells Dr Reddy's on antirheumatic drug Abatacept study Dr. Divya Colin3 Feb 2024 6:00 PM ISTNew Delhi: The drug major Dr Redyy's Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Conduct post marketing clinical study to generate safety data of Nerivio: CDSCO panel Tells Dr Reddy's Lab Dr. Divya Colin6 Dec 2023 6:00 PM ISTNew Delhi: Considering the drug major Dr. Reddys Laboratorie's proposal to import the Nerve Electrical Stimulator (Brand Name: Nerivio) intended for...
Dr. Reddy's gets CDSCO Panel Nod To Study weight loss drug Semaglutide injection Dr. Divya Colin18 Oct 2023 6:15 PM ISTNew Delhi: The drug major Dr. Reddy's Laboratories has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug...
Revise Phase III CT protocol of Olokizumab as a single-arm study: CDSCO Panel Tells Dr Reddys Dr. Divya Colin17 Oct 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined the drug major Dr...
Cipla founding family faces hurdles in stake sale as valuation hits USD 13 billion mark: Bloomberg Farhat Nasim16 Sept 2023 4:42 PM ISTNew Delhi: The sale of a stake in Cipla Ltd. is in jeopardy as potential buyers have balked at the 1.09 trillion rupee ($13.1 billion) valuation...
Cipla Buyout Battle: Dr Reddys, Bain Capital to team up for joint bid? Drugmaker issues statement Farhat Nasim6 Sept 2023 3:36 PM ISTNew Delhi: The buyout battle for 33.47 percent promoter stake in Cipla, owned by the Hamied family has intensified as US-based private equity...
CDSCO Panel Rejects Dr. Reddy's Proposal For Ketorolac Tromethamine plus Serratiopeptidase FDC Dr. Divya Colin7 Aug 2023 6:00 PM ISTNew Delhi: Citing there is no rationality data, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization...
Revise Phase IV clinical trial protocol of Nimesulide Granules for oral suspension: CDSCO Panel Tells Dr Reddys Dr. Divya Colin18 Jun 2023 11:00 AM ISTNew Delhi: The Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) has recommended the drug major Dr....
Dr. Reddy's Gets CDSCO Panel Nod to study gastric acid blocker Vonoprazan fumarate Dr. Divya Colin1 Jun 2023 6:00 PM ISTNew Delhi: In line with the bioequivalence (BE) study report, the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
Submit Animal Toxicity Data: CDSCO panel Tells Dr. Reddy's on Ferric carboxymaltose injection Dr. Divya Colin14 May 2023 6:00 PM ISTNew Delhi: In response to the drug major Dr. Reddy's Laboratories' proposal to manufacture and market the Ferric Carboxymaltose Injection, the Subject...
